Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
Start Over | Back to Previous Screen
Hydromorphone Hydrochloride Injection
Status: Currently in Shortage
»Date first posted:
10/31/2017
»Therapeutic Categories: Analgesia/Addiction
Akorn Pharmaceuticals (Reverified 05/19/2021)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 10 mg/mL, 1 mL ampule, 10 count (NDC 17478-0540-01) | Available | ||
| 10 mg/mL, 5 mL ampule, 10 count (NDC 17478-0540-05) | Available | Demand increase for the drug | |
| 10 mg/mL, 50 mL vial, 10 count (NDC 17478-0540-50) | Available | Demand increase for the drug |
Fresenius Kabi USA, LLC (Revised 09/14/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| (Dilaudid) 0.5 mg per 0.5 mL, prefilled syringe (NDC 76045-009-06) | Check wholesalers for inventory | Check wholesalers for inventory | Demand increase for the drug |
| (Dilaudid) 1 mg per 1 mL, prefilled syringe (NDC 76045-009-10) Blister pack | Check wholesalers for inventory | Demand increase for the drug | |
| (Dilaudid) 2 mg per 1 mL, prefilled syringe (NDC 76045-010-10) | Backordered. Next release date not available at this time. | Demand increase for the drug | |
| (Dilaudid) 4 mg per 1 mL, prefilled syringe (NDC 76045-011-10) | Backordered. Next release date not available at this time. | Demand increase for the drug | |
| 1 mg per 1 mL, Single dose vial, (NDC 63323-852-25) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 2 mg per 1 mL, Single dose vial, (NDC 63323-853-25) | Backordered. Next release September 2022. | Check wholesalers for inventory | Demand increase for the drug |
| 4 mg per 1 mL, Single dose vial, (NDC 63323-854-10) | Backordered. Next release not available at this time. | Check wholesalers for inventory | Demand increase for the drug |
| 10 mg per 1 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-10) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 50 mg per 5 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-15) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 500 mg per 50 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-50) | Available | Check wholesalers for inventory | Demand increase for the drug |
| (Dilaudid) 0.5 mg per 0.5 mL, prefilled syringe (NDC 76045-009-06) Microvault | Available | ||
| (Dilaudid) 1 mg per 1 mL, prefilled syringe (NDC 76045-009-11) Microvault | Available | ||
| (Dilaudid) 0.2 mg per 1 mL, prefilled syringe, MicroVault packaging (NDC 76045-121-11) | Available | ||
| (Dilaudid) 2 mg per 1 mL, prefilled syringe, MicroVault packaging (NDC 76045-010-11) | Available |
Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 04/08/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2 mg/mL, 1 mL vial (NDC 0641-0121-25) | This presentation is temporarily on backorder. | Demand increase for the drug | |
| 2 mg/mL, 20 mL vial (NDC 0641-2341-41) | This presentation is temporarily on backorder. | Demand increase for the drug |
Hospira, Inc. (Revised 09/12/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 0.5 mg/0.5 mL (1 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1283-05) | Limited Supply Available. Next Delivery and Estimated Recovery: October 2022 | Shortage per Manufacturer: Manufacturing Delay | Other |
| 1 mg/1 mL (1 mg/1 mL); iSecure Luer Lock Glass Syringe (NDC 00409-1283-10) | Discontinued | Discontinuation of the manufacture of the drug | |
| 2 mg/1 mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1312-10) | Discontinued | Discontinuation of the manufacture of the drug | |
| 1 mg/1 mL (1 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1283-31) | Available | Demand increase for the drug | |
| 2 mg/1 mL (2 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1312-30) | Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: October 2022 | Demand increase for the drug | |
| 4 mg/1 mL (4 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1304-31) | Available | Other | |
| 1 mg/1 mL (1 mg/mL); Glass Ampul (NDC 00409-2552-01) | Next Delivery and Estimated Recovery: September 2022 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Demand increase for the drug |
| 2 mg/1 mL (2 mg/mL); Glass Ampul (NDC 00409-3356-01) | Discontinued | Discontinuation of the manufacture of the drug | |
| 4 mg/1 mL (4 mg/mL); Glass Ampul (NDC 00409-2540-01) | Discontinued | Discontinuation of the manufacture of the drug | |
| 2 mg/1 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3365-01) | Discontinued | Discontinuation of the manufacture of the drug | |
| 10 mg/mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-01) | Available | Other | |
| 50 mg/5 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-05) | Available | Other | |
| 500 mg/50 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-50) | Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: January 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
Teva Pharmaceuticals (Reverified 10/05/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 10 MG/1ML (NDC0703-0110-03) | Available | ||
| 10 MG/1ML (NDC 0703-0113-03) | Available | ||
| 10 MG/1 ML (NDC 0703-0018-01) | Available |